Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.
about
Optimal usage of the GnRH antagonists: a review of the literatureGonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technologyGonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesGonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cyclesGnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysisOocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidanceGnRH agonist for triggering of final oocyte maturation: time for a change of practice?A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryosThe mechanism responsible for the supraphysiologic gonadotropin surge in females treated with gonadotropin-releasing hormone (GnRH) agonist and primed with GnRH antagonist.Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial.Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition.Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist ProtocolThe safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?GnRH analogues in the prevention of ovarian hyperstimulation syndromeCombination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels--a retrospective studyGnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?Approaches to improve the diagnosis and management of infertilityGonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial.GnRH antagonist, cetrorelix, for pituitary suppression in modern, patient-friendly assisted reproductive technology.OHSS Free Clinic.GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future.Rescue hCG to treat empty follicle syndrome after the use of a GnRH agonist as oocyte maturation trigger: First report on fresh embryo transfer and clinical pregnancy.Fresh embryos versus freeze-all embryos - transfer strategies: Nuances of a meta-analysis.GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.What is the net effect of introducing vitrification for cryopreservation of surplus 2PN oocytes in an IVF program?The effect of an immediate frozen embryo transfer following a freeze-all protocol: a retrospective analysis from two centres.Blastocyst-stage versus cleavage-stage embryo transfer in the first frozen cycles of OHSS-risk patients who deferred from fresh embryo transfer.
P2860
Q21245566-63012B97-7C5F-463F-A950-860D9897A32DQ24193015-DD7E616E-6B12-40B0-A5CD-C6EC28C164DAQ24234765-726FDA8A-D354-4B17-B966-FF1B528A3980Q24236630-0E829D7A-B3DD-4945-B528-2C1E300D1DF3Q26800033-EC6DBFC2-CE36-4096-B779-0C8AD404799DQ28077375-1ED01DD7-AC64-448A-9FDE-A622EA2176B0Q28308094-851ACE63-AE99-4B2E-A9F3-08F1FEC468D8Q30052736-7B67E063-DBD9-4C25-8C3B-65251E9F117CQ33805486-C5799800-F4D5-4783-BFC3-42B17CF724B4Q34866439-9C5EC28F-1BB5-4020-9E51-D120AB8C8DCDQ34928751-E2E13688-DFA3-4F6E-BDA7-FC356E034BB0Q35938164-4F2F9D9D-1D19-4872-9550-A0573A89D5F9Q35947620-204796BD-7983-482A-BAFF-D457DB57C3C3Q36319447-0391CF47-ABFF-45C9-B6E0-B57524A45B77Q36756209-72626A28-115D-44B4-98C3-47E8FE2622E2Q36957480-DF47DEFC-61F4-495C-8E5E-289752E8392EQ36966423-943437AA-7AD9-49B6-843D-36491FB27AE0Q36970343-612EF7AF-59BE-4C91-AD47-380F861FED8EQ37214916-8250E466-DBD6-47DA-9F6D-16C17530ABB3Q37350477-617D1D8D-E6F2-453C-A918-CC677ADC4366Q37598922-A4D5CE3F-461A-49D8-8469-91865B1A0DDFQ37709815-125D49BE-BFC2-498A-9F6C-C13BC9E9E76CQ38222516-DE8856CD-A216-481A-8111-A914561AEA36Q38591940-90DA78DE-373C-4292-A30B-1779C99A97E0Q38610421-D4C8610C-329C-40BD-ABF1-3F2C0ABB9597Q41725757-B992F054-6F49-4DB0-A0D5-48928978A2F9Q45301872-43CA4ED6-F22C-4620-BCD1-ABFC2DB317F2Q47326161-19C24653-CDBF-4213-A647-421D9FD76DCFQ48542271-53A3BBF6-1BD1-453C-9474-9D11615ECE17Q52929795-A0025C81-7B24-402F-AEE4-A1B47B26D519
P2860
Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Elective cryopreservation of a ...... tional proof-of-concept study.
@en
type
label
Elective cryopreservation of a ...... tional proof-of-concept study.
@en
prefLabel
Elective cryopreservation of a ...... tional proof-of-concept study.
@en
P2093
P2860
P356
P1433
P1476
Elective cryopreservation of a ...... tional proof-of-concept study.
@en
P2093
Al-Hasani S
Diedrich K
Griesinger G
Schultze-Mosgau A
von Otte S
P2860
P304
P356
10.1093/HUMREP/DEM006
P407
P577
2007-02-15T00:00:00Z